Management of relapsed/refractory high-risk neuroblastoma

Management of relapsed/refractory high-risk neuroblastoma
May 9, 2021 ology
Current Status
Not Enrolled
Price
Free
Get Started

Learn from leading experts how to integrate immunotherapy-based approaches into individualized treatment plans for patients with high-risk relapsed/refractory neuroblastoma.

This activity is supported by an independent educational grant from Y-mAbs Therapeutics, Inc.